Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and incidence of asthma and wheeze in childhood: A register-based cohort study in Ronneby, Sweden
PLOS Medicine · 09.04.2026 · 23 (4) · e1004659
DOI: 10.1371/journal.pmed.1004659 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift PLOS Medicine, online erschienen am 09.04.2026. Verfasst von Annelise J Blomberg und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Occupational and Environmental Medicine, Department of Laboratory Medicine, Lund University, Lund, Sweden. Hauptthemen laut MEDLINE: Asthma, Prenatal Exposure Delayed Effects, Respiratory Sounds, Fluorocarbons. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: HORIZON EUROPE Marie Sklodowska-Curie Actions, ForskningsrÃ¥det om Hälsa, Arbetsliv och Välfärd.
Abstract (Originalsprache)
Background
Early-life exposure to per- and polyfluoroalkyl substances (PFAS) may impact the developing lungs and immune system and increase the risk of childhood asthma, but no studies have been conducted in a high-exposed population. The objective of this study was to estimate associations between prenatal PFAS exposure and childhood incidence of asthma and wheeze in Blekinge County, Sweden, where a subset of residents in the city of Ronneby was exposed to PFAS from drinking water contaminated by aqueous film-forming foam (AFFF). Methods and findings We constructed a register-based open cohort of 11,488 children born in Blekinge county between 2006 and 2013 and followed each individual from birth until age 12 or December 31, 2022. Maternal address history was linked to water distribution records to create a categorical proxy variable for prenatal PFAS exposure from drinking water. We identified incident cases of wheeze and asthma from administrative health records and estimated hazard ratios (HRs) using Cox proportional hazards models adjusted for individual-level confounders, including maternal smoking in early pregnancy, maternal age at delivery, parity, child sex, parental asthma, and socioeconomic factors. As a secondary analysis, we applied a Rubin Causal Model (RCM) analysis to estimate the average marginal effect of prenatal PFAS exposure on wheeze and asthma among the very highly-exposed population, using a matched dataset of very-high and background-exposed individuals balanced on measured confounders. Overall, 18% of children were diagnosed with wheeze and 17% with asthma during follow-up. Very high prenatal PFAS exposure was associated with incidence of asthma (HR: 1.44, 95% CI [1.08, 1.92]), whereas no associations were observed for the high or intermediate exposure groups or for wheeze. In the RCM analysis, the estimated cumulative incidence of asthma was 16.1% in the background-exposed group and 26.7% in the very highly exposed group (Fisherian p < 0.001). Study limitations include reliance on an address-based categorical proxy for prenatal PFAS exposure, which likely results in non-differential exposure misclassification and limits the ability to distinguish prenatal from early-childhood exposure effects.
Conclusions
In this study, very high prenatal PFAS exposure was associated with a higher incidence of childhood asthma. Although these results should be replicated, they suggest an important public health impact of AFFF-associated PFAS contamination.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Occupational and Environmental Medicine, Department of Laboratory Medicine, Lund University, Lund, Sweden.
- Department of Clinical Pharmacology, Pharmacy and Environmental Medicine, Institute of Public Health, University of Southern Denmark, Odense, Denmark.
- Center for Primary Health Care Research, Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden.
- University Clinic Primary Care Skåne, Region Skåne, Sweden.
- Biostatistics Center, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
- Department of Medicine, Harvard Medical School, Boston, Massachusetts, United States of America.
ORCID-Profile: Annelise J Blomberg, Christel Nielsen, Beata Borgström Bolmsjö, Linda Hartman, Anna Saxne Jöud
Förderung
- HORIZON EUROPE Marie Sklodowska-Curie Actions
- Forskningsrådet om Hälsa, Arbetsliv och Välfärd
Zitieren
APA
Blomberg, A. J., Nielsen, C., Borgström Bolmsjö, B., Bind, M. A., Hartman, L., & Saxne Jöud, A. (2026). Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and incidence of asthma and wheeze in childhood: A register-based cohort study in Ronneby, Sweden. PLOS Medicine, 23(4), e1004659. https://doi.org/10.1371/journal.pmed.1004659
Vancouver
Blomberg AJ, Nielsen C, Borgström Bolmsjö B, Bind MA, Hartman L, Saxne Jöud A. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and incidence of asthma and wheeze in childhood: A register-based cohort study in Ronneby, Sweden. PLOS Medicine. 2026;23(4):e1004659. doi:10.1371/journal.pmed.1004659
BibTeX
@article{Blomberg2026,
author = {Blomberg, Annelise J and Nielsen, Christel and Borgström Bolmsjö, Beata and Bind, Marie-Abèle and Hartman, Linda and Saxne Jöud, Anna},
title = {Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and incidence of asthma and wheeze in childhood: A register-based cohort study in Ronneby, Sweden},
journal = {PLOS Medicine},
year = {2026},
volume = {23},
number = {4},
pages = {e1004659},
doi = {10.1371/journal.pmed.1004659}
}
EUVIMED